Latest news
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1 - tipranks.comtipranks.com · Thu, 06 Aug 2026 01:23:12 GMTTakeda Tracks Real World Safety of Ceprotin (TAK-662) in Rare Clotting Disorder - tipranks.comtipranks.com · Fri, 31 Jul 2026 17:17:56 GMTAnalysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 17:06:00 GMTTakeda Targets Infection Risks in Older IBD Patients With New ENTYVIO Safety Study - tipranks.comtipranks.com · Mon, 27 Jul 2026 16:40:07 GMT